180 Life Sciences Secures $425 Million in Private Placement to Enhance Ethereum Treasury Strategy
180 Life Sciences has taken a bold step in its growth plan. The biotech company has closed a $425 million private placement to boost its work and reshape how it manages its money. Instead of following the usual cash‑only route, the firm plans to use part of these funds to build a treasury in Ethereum, one of the world’s leading blockchain networks.
Continue Reading on Meyka
This article is available in full on our main platform. Get access to complete analysis, stock insights, and more.
Read Full Article →
